Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02447003
Brief Title: Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)

First Submitted : May 14, 2015
First Submitted that Met QC Criteria : May 14, 2015
First Posted : May 18, 2015 (Estimate)

Results First Submitted : November 18, 2020
Results First Submitted that Met QC Criteria : November 18, 2020
Results First Posted : December 16, 2020

Last Update Submitted that Met QC Criteria : November 18, 2020
Last Update Posted : December 16, 2020